Progesterone Market Size, Share & Trends Report

Progesterone Market (2024 - 2030) Size, Share & Trends Analysis Report By Type (Synthetic, Natural), By Mode Of Delivery (Injectable, Oral, Suspended Forms), By Application, By Region, And Segment Forecasts

Market Segmentation

Women’s Health Application Outlook (Revenue, USD Million, 2021 - 2033)
- Hormonal Infertility
- Contraceptives
- Postmenopausal Osteoporosis
- Endometriosis & Uterine Fibroids
- Menopause
- Polycystic Ovary Syndrome (PCOS)
Women’s Health Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
- Hormonal Therapies
- Bone Health Agents
- Fertility Agents
- GnRH Modulators
- Pain and Symptom Management
- Metabolic Agents
- Others
Women’s Health Age Outlook (Revenue, USD Million, 2021 - 2033)
- 50 years and above
  - Postmenopausal Osteoporosis
  - Endometriosis & Uterine Fibroids
  - Menopause
  - Others
- Others
Women’s Health Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - Women’s Health Market, by Application
    - Hormonal Infertility
    - Contraceptives
    - Postmenopausal Osteoporosis
    - Endometriosis & Uterine Fibroids
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Women’s Health Market, by Drug Class
    - Hormonal Therapies
    - Bone Health Agents
    - Fertility Agents
    - GnRH Modulators
    - Pain and Symptom Management
    - Metabolic Agents
    - Others
  - Women’s Health Market, by Age
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - U.S.
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Canada
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Mexico
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
- Europe
  - Women’s Health Market, by Application
    - Hormonal Infertility
    - Contraceptives
    - Postmenopausal Osteoporosis
    - Endometriosis & Uterine Fibroids
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Women’s Health Market, by Drug Class
    - Hormonal Therapies
    - Bone Health Agents
    - Fertility Agents
    - GnRH Modulators
    - Pain and Symptom Management
    - Metabolic Agents
    - Others
  - Women’s Health Market, by Age
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - UK
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Germany
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - France
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Italy
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Spain
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Denmark
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Sweden
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Norway
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
- Asia Pacific
  - Women’s Health Market, by Application
    - Hormonal Infertility
    - Contraceptives
    - Postmenopausal Osteoporosis
    - Endometriosis & Uterine Fibroids
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Women’s Health Market, by Drug Class
    - Hormonal Therapies
    - Bone Health Agents
    - Fertility Agents
    - GnRH Modulators
    - Pain and Symptom Management
    - Metabolic Agents
    - Others
  - Women’s Health Market, by Age
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Japan
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - China
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - India
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Australia
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - South Korea
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Thailand
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
- Latin America
  - Women’s Health Market, by Application
    - Hormonal Infertility
    - Contraceptives
    - Postmenopausal Osteoporosis
    - Endometriosis & Uterine Fibroids
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Women’s Health Market, by Drug Class
    - Hormonal Therapies
    - Bone Health Agents
    - Fertility Agents
    - GnRH Modulators
    - Pain and Symptom Management
    - Metabolic Agents
    - Others
  - Women’s Health Market, by Age
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - Brazil
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Argentina
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
- Middle East & Africa
  - Women’s Health Market, by Application
    - Hormonal Infertility
    - Contraceptives
    - Postmenopausal Osteoporosis
    - Endometriosis & Uterine Fibroids
    - Menopause
    - Polycystic Ovary Syndrome (PCOS)
  - Women’s Health Market, by Drug Class
    - Hormonal Therapies
    - Bone Health Agents
    - Fertility Agents
    - GnRH Modulators
    - Pain and Symptom Management
    - Metabolic Agents
    - Others
  - Women’s Health Market, by Age
    - 50 years and above
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Others
    - Others
  - South Africa
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Saudi Arabia
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - UAE
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others
  - Kuwait
    - Women’s Health Market, by Application
      - Hormonal Infertility
      - Contraceptives
      - Postmenopausal Osteoporosis
      - Endometriosis & Uterine Fibroids
      - Menopause
      - Polycystic Ovary Syndrome (PCOS)
    - Women’s Health Market, by Drug Class
      - Hormonal Therapies
      - Bone Health Agents
      - Fertility Agents
      - GnRH Modulators
      - Pain and Symptom Management
      - Metabolic Agents
      - Others
    - Women’s Health Market, by Age
      - 50 years and above
        
        Postmenopausal Osteoporosis
        
        Endometriosis & Uterine Fibroids
        
        Menopause
        
        Others
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments